13 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
.
Policies Regarding the Representation of Women on the Board
The Company does not have a written policy relating to the identification … and nomination of women directors. When considering and recommending qualified director nominees, the Compensation, Nominating and Governance Committee evaluates
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
23 May 22
Annual General Meeting of the Shareholders
4:29pm
.
Policies Regarding the Representation of Women on the Board
The Company does not have a written policy relating to the identification and nomination … of women directors. When considering and recommending qualified director nominees, the Compensation, Nominating and Governance Committee evaluates all
20-F
2021 FY
QNTM
Quantum BioPharma Ltd
31 Mar 22
Annual report (foreign)
8:09am
healthy adult men and women enrolled. The trial sequentially tested single ascending doses ranging from 600 mg to 2400 mg tablets and multiple … a term limit for directors is necessary or appropriate at this time.
Policies Regarding the Representation of Women on the Board
The Company does
6-K
EX-99.1
bupmx6r15ptphqs
5 May 21
Current report (foreign)
11:30am
6-K
EX-99.1
uuom1apbifh ewz5pxc
23 Apr 21
Current report (foreign)
5:24pm
40-F
EX-99.1
4sx1xas oh5
17 Mar 21
Annual report (Canada)
12:00am
SUPPL
aphujeyuxo3aoztxnh
11 Feb 21
Supplemental materials (foreign)
8:32am
SUPPL
dvle zl2q
16 Oct 20
Supplemental materials (foreign)
5:19pm
SUPPL
au02j148pdh9uduryp
31 Jul 20
Supplemental materials (foreign)
9:43pm
SUPPL
mucug
13 Jul 20
Supplemental materials (foreign)
12:00am
6-K
EX-99.1
ivesi6wk
22 Jun 20
FSD Pharma Reports Favorable Topline Results from Phase 1 First-in-Human Safety and Tolerability Study of Ultramicronized PEA
11:40am
- Prev
- 1
- Next